Apogee Therapeutics, Inc.
General ticker "APGE" information:
- Sector: Health Care
- Industry: Biotechnology
- Capitalization: $2.4B (TTM average)
Apogee Therapeutics, Inc. follows the US Stock Market performance with the rate: 48.8%.
Estimated limits based on current volatility of 2.3%: low 74.43$, high 77.97$
Factors to consider:
- Total employees count: 91 as of 2023
- Current price 17.9% above estimated high
- Earnings for 9 months up through Q3 are below our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2024-12-31 to 2026-12-31
- 2024-12-31 to 2025-12-31 estimated range: [25.88$, 64.89$]
- 2025-12-31 to 2026-12-31 estimated range: [18.69$, 48.89$]
Short-term APGE quotes
Long-term APGE plot with estimates
Financial data
| YTD | 2022-12-31 | 2023-12-31 | 2024-12-31 |
|---|---|---|---|
| Operating Revenue | $0.00MM | $0.00MM | $0.00MM |
| Operating Expenses | $30.73MM | $93.00MM | $216.87MM |
| Operating Income | $-30.73MM | $-93.00MM | $-216.87MM |
| Non-Operating Income | $-9.06MM | $9.02MM | $34.74MM |
| Interest Expense | $9.15MM | $0.00MM | $0.00MM |
| R&D Expense | $27.79MM | $68.42MM | $167.87MM |
| Income(Loss) | $-39.78MM | $-83.98MM | $-182.13MM |
| Taxes | $0.00MM | $0.00MM | $0.02MM |
| Profit(Loss)* | $-39.78MM | $-83.98MM | $-182.15MM |
| Stockholders Equity | $142.07MM | $379.91MM | $716.79MM |
| Assets | $152.06MM | $401.40MM | $753.95MM |
| Operating Cash Flow | $-16.43MM | $-74.76MM | $-171.17MM |
| Capital expenditure | $0.00MM | $0.17MM | $1.15MM |
| Investing Cash Flow | $0.00MM | $-273.91MM | $-300.46MM |
| Financing Cash Flow | $168.32MM | $315.39MM | $495.11MM |
| Earnings Per Share** | $-0.79 | $-1.66 | $-3.30 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.